Symic Biomedical's Series A - II Round

Symic Biomedical raised a round of funding on December 01, 2015.

Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology. The Symic Bio platform of matrix-targeting biotherapeutics builds upon emerging research o…

Articles about Symic Biomedical's Series A - II Round: